ArticleAIDS and behavior2026
A Decade of Improvement and Signs of Decline in PrEP Awareness and Use in Young Trans Women.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The risk of HIV is significantly higher in transgender women compared to the general population, with young trans women having higher incidence compared to older trans women. Effective efforts to ensure PrEP uptake and persistence among young trans women is key to addressing the HIV epidemic in the U.S. We analyzed serial cross-sectional data from the Trans women Empowered to Advance Community Health (TEACH) studies conducted in San Francisco in 2013, 2016-2017, 2019-2020, and 2023-2024. Our study included 83 young adult (18-26 years old) trans women living without HIV. We used the Cochran-Armitage test for trends to assess changes in PrEP awareness, use, and key HIV risk and preventive behaviors. PrEP awareness among young trans women significantly increased from 6% in 2013, 94% in 2016-2017, 100.0% in 2019-2020, and 86% in 2023-2024 (z = 7.96, p < 0.001). PrEP use also significantly increased from 0% in 2013, 19% in 2016-2017, 46% in 2019-2020, and 36% in 2023-2024 (z = 9.90, p < 0.001). Meanwhile, condomless sex in the last 12 months has risen from 33% in 2013 to 86% in 2023-2024 (z = 4.15, p < 0.001). PrEP awareness and use have significantly increased among young trans women in San Francisco since FDA approval in 2012. However, our study points to a potential leveling off or decrease in PrEP awareness and use in recent years. Furthermore, PrEP use still lags need. Young trans women must be prioritized in PrEP awareness and demand creation efforts in addition to efforts to support adherence and persistence.
Indexed as
Identifiers
42461486What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.